Not One-Size-Fits-All: Personalizing Chemotherapy for Better Results
- 13 hours ago
- 2 min read
What is this interview about?
This interview with Dr. Kiran Turaga explains a new approach to treating abdominal cancers called personalized chemotherapy.
Instead of giving every patient the same treatment, doctors are working to match chemotherapy to each person’s specific tumor—so it works better and causes fewer side effects.
Why is this important?
Abdominal cancers (like colorectal, appendix, or ovarian cancers that spread in the abdomen) can be difficult to treat because:
Tumors vary from person to person
Standard chemotherapy doesn’t work the same for everyone
Some patients may receive treatments that are less effective for their specific cancer
Personalized chemotherapy aims to solve this “one-size-fits-all” problem.
How does personalized chemotherapy work?
Doctors use a patient’s tumor (often from a biopsy or surgery) to test how it responds to different chemotherapy drugs.
They expose tumor samples to different treatments
They measure which drugs are most effective at killing those cancer cells
They then choose the best treatment for that individual patient
This approach helps doctors make more informed, tailored treatment decisions.
What are the potential benefits?
More effective treatment
Patients may receive drugs that are more likely to work for their specific cancer
Fewer unnecessary side effects
Avoiding ineffective treatments can reduce exposure to toxicity and side effects
Faster decision-making
Testing tumors directly can help doctors choose treatments sooner and more confidently
How does this relate to current treatments like HIPEC?
For some abdominal cancers, treatment may include surgery plus HIPEC (heated chemotherapy in the abdomen).
Personalized approaches could help determine:
Which chemotherapy drugs to use during HIPEC
Which patients are most likely to benefit
This could make advanced treatments like HIPEC even more effective.
What are the challenges?
This approach is still being studied and is not yet standard everywhere
More research is needed to confirm how well it improves outcomes
It requires specialized testing and expertise
What does this mean for patients?
Personalized chemotherapy is a promising step toward more tailored cancer care
It may help patients receive treatments that are more effective and better tolerated
It is often available through clinical trials or specialized cancer centers
Patients can ask their care team:
“Is personalized chemotherapy an option for me?”
“Are there clinical trials I should consider?”
Bottom line
Personalized chemotherapy is an emerging approach that tests a patient’s tumor to find the most effective treatment. While still being studied, it represents an important shift toward more precise, individualized care for abdominal cancers.
